Related Experiment Video
Updated: Aug 18, 2026
Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Anti-macrophage CR3 antibody blocks myelin phagocytosis by macrophages in vitro
1Abteilung für Neuropathologie, Universität Göttingen, Federal Republic of Germany.
Abstract:
Myelin phagocytosis in Wallerian degeneration of peripheral nerves depends on invasion of nerves by non-resident macrophages. The present study was done to clarify the role of the macrophage complement receptor type 3 (CR3) in myelin removal. Myelin phagocytic capacity of invading macrophages was abolished by treatment of cultured nerves and macrophages with anti-CR3 antibody or by serum complement depletion with cobra venom factor. This indicates that myelin phagocytosis is mediated by the macrophage CR3.
Insights
Macrophage complement receptor type 3 (CR3) is essential for myelin removal during Wallerian degeneration in peripheral nerves. Blocking CR3 activity prevents macrophages from clearing myelin debris, highlighting its critical role in nerve repair.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Wallerian degeneration involves peripheral nerve myelin breakdown.
- Non-resident macrophages are crucial for myelin phagocytosis during this process.
Purpose of the Study:
- To investigate the specific role of macrophage complement receptor type 3 (CR3) in myelin phagocytosis.
- To elucidate the mechanism by which macrophages clear myelin debris.
Main Methods:
- Cultured peripheral nerves and macrophages were used.
- Treatment involved anti-CR3 antibody and serum complement depletion using cobra venom factor.
Main Results:
- Myelin phagocytic capacity of invading macrophages was abolished by anti-CR3 antibody treatment.
- Complement depletion also eliminated myelin phagocytosis, confirming CR3's involvement.
Conclusions:
- Macrophage CR3 is essential for mediating myelin phagocytosis during Wallerian degeneration.
- Targeting CR3 may offer therapeutic strategies for enhancing nerve repair.
